Alkem Foundation, IIT Bombay to Set Up Advanced Research Centre

05 Nov 2025 CW Team

Under this partnership, Alkem Foundation will fund the creation of the Alkem Centre for Advanced Research and Development of Applied Immuno-Therapeutics and Regenerative Medicines within the IIT Bombay campus. The foundation will contribute around 20–25 per cent of its cumulative CSR obligations over seven years towards this project.

The initiative marks India’s first industry–academia collaboration, initiated through the CSR route, to promote advanced research in these complex therapeutic areas. It will combine Alkem’s experience in developing pharmaceutical solutions with IIT Bombay’s expertise in biomedical engineering, biosciences, and translational research to create an innovation-driven ecosystem.

The centre aims to build a holistic platform for research, innovation, and skill development in high-precision and underserved therapy areas, bridging gaps in infrastructure, talent, and translational capability. It will also align with IIT Bombay’s multidisciplinary healthcare approach that integrates biology, engineering, and data science to advance human health.

Future research will explore frontier domains such as gene editing, biomaterials, and delivery technologies for immuno-therapeutics and regenerative medicine. The centre will serve as a hub for clinician-scientists and biotech entrepreneurs, supported by IIT Bombay faculty, Alkem mentors, and global experts from leading universities.

Madhurima Singh, Executive Director and Chairperson, CSR and Sustainability Committee, Alkem, said, “We believe in going beyond business to support R&D in areas of significant medical need. Our partnership with IIT Bombay reflects a shared commitment to fostering innovation and developing advanced, affordable treatments that can enhance both lifespan and quality of life.”

Prof. Shireesh B. Kedare, Director, IIT Bombay, added, “This collaboration will accelerate translation of cutting-edge research into real-world healthcare impact, helping India achieve self-reliance in biomedical innovation.”

Mumbai, November 3, 2025 — Alkem Foundation, the Corporate Social Responsibility (CSR) arm of Alkem Laboratories, has announced a strategic collaboration with the Indian Institute of Technology Bombay (IIT Bombay) to establish a first-of-its-kind research centre in India dedicated to immuno-therapeutics and regenerative medicines. Under this partnership, Alkem Foundation will fund the creation of the Alkem Centre for Advanced Research and Development of Applied Immuno-Therapeutics and Regenerative Medicines within the IIT Bombay campus. The foundation will contribute around 20–25 per cent of its cumulative CSR obligations over seven years towards this project. The initiative marks India’s first industry–academia collaboration, initiated through the CSR route, to promote advanced research in these complex therapeutic areas. It will combine Alkem’s experience in developing pharmaceutical solutions with IIT Bombay’s expertise in biomedical engineering, biosciences, and translational research to create an innovation-driven ecosystem. The centre aims to build a holistic platform for research, innovation, and skill development in high-precision and underserved therapy areas, bridging gaps in infrastructure, talent, and translational capability. It will also align with IIT Bombay’s multidisciplinary healthcare approach that integrates biology, engineering, and data science to advance human health. Future research will explore frontier domains such as gene editing, biomaterials, and delivery technologies for immuno-therapeutics and regenerative medicine. The centre will serve as a hub for clinician-scientists and biotech entrepreneurs, supported by IIT Bombay faculty, Alkem mentors, and global experts from leading universities. Madhurima Singh, Executive Director and Chairperson, CSR and Sustainability Committee, Alkem, said, “We believe in going beyond business to support R&D in areas of significant medical need. Our partnership with IIT Bombay reflects a shared commitment to fostering innovation and developing advanced, affordable treatments that can enhance both lifespan and quality of life.” Prof. Shireesh B. Kedare, Director, IIT Bombay, added, “This collaboration will accelerate translation of cutting-edge research into real-world healthcare impact, helping India achieve self-reliance in biomedical innovation.”

Technology

29 Jul 2026

AI-Enabled Workflows Lift Profitability and Productivity

Organisations modernising frontline workflows with artificial intelligence, automation and real-time data are reporting stronger financial performance, higher productivity and improved employee engagement, according to a global study by Zebra Technologies and Oxford Economics.The research covered 1,000 senior leaders across retail, manufacturing, transportation and logistics in the US, Mexico, the UK, Germany, India, Japan, Australia and New Zealand.In transportation and logistics, 54 per cent of companies that improved picking and packing operations reported faster operational performance, wh..

Real Estate

29 Jul 2026

India Leads Global AI Readiness but Implementation Lags

Indian companies lead global averages across all eight artificial intelligence readiness indicators tracked by JLL, but only 19 per cent have started making changes to their workplaces, according to the JLL 2026 Future of Work Survey.The study found that 77 per cent of Indian business leaders expect AI to change their office requirements, creating a 58-percentage-point gap between awareness and implementation. The survey covered more than 2,200 CEOs, CFOs and real estate leaders across 21 countries during the first quarter of 2026.Despite concerns over automation, 58 per cent of Indian leaders..

Equipment

29 Jul 2026

Three WOLFF Cranes Build Riyadh Cable-Stayed Bridges

Three WOLFF 180 B luffing jib cranes are supporting the construction of two cable-stayed bridges alongside the existing Wadi Laban Bridge in Riyadh, Saudi Arabia. The project is being developed for the Royal Commission for Riyadh City and executed by the ICRC joint venture comprising IC Ictas and Al Rashid Trading & Contracting Company.The cranes are handling lifting operations including formwork, reinforcement, concrete placement, work platforms, surveying equipment and other construction materials. Each crane is fitted with a 40 m jib, reaches a hook height of 157 m and offers a maximum ..